2019 BioHealth Capital Region Forum

Top 3 by 2023

Miss the 2019 BioHealth Capital Region Forum?

 

20% of the top influencers worldwide in vaccine development

 

World-class tech + big data + biotech + White House Precision Medicine Initiative = new frontiers in patient-centered medicine

1
1

MD | DC | VA

Our Goal: To become a Top 3 BioHealth Hub by 2023.

We are the research engine for the nation and the world. A lifeblood of support for taking new medicines to market. A place where health policymakers and patient advocates seek a better way forward. A home to the established and the startup, pioneering big ideas for human health and hope.

Driving Innovation and Entrepreneurship

  • World–renowned research institutions and universities
  • Influential policymakers and advocacy groups pioneering new health strategies
  • World–leading infectious disease research and vaccine development
  • Fastest growing region for healthcare companies in the U.S.
  • Rated #1 in the nation for science and engineering talent
  • Mission control for the National Cancer Moonshot Initiative

Founding Partners

Emergent BioSolutions’ New President and CEO, Bob Kramer, joins Rich Bendis on BioTalk

August 20, 2019

Bob Kramer joins BioTalk to discuss his history with Emergent, his vision for the company, and Emergent’s commitment to the BioHealth Capital Region. Mr. Kramer serves as president and CEO…

ivWatch Headquarter Operations Opens Doors on Aug. 16 for Ribbon-Cutting

August 13, 2019

Medical device manufacturer welcomes visitors during Tech Center event NEWPORT NEWS, Va., August 13, 2019 – ivWatch, a biosensor technology company focused on improving patient safety and the effectiveness of intravenous…

BioHealth Innovation’s Entrepreneur-In-Residence, Dr. Ethel Rubin, joins Rich Bendis on BioTalk to discuss her career, joining BHI, and her work with the NIH

August 12, 2019

For the first time, a BioTalk look inside BioHealth Innovation, Inc. (BHI) with Entrepreneur-In-Residence (EIR) Dr. Ethel Rubin Dr. Ethel Rubin leads a venture team that helps prepare and connect…

RoosterBio Raises $15 Million in Initial Series B Round Led by Dynamk Capital

August 6, 2019

New Funding, Anticipated to Close at $22 Million, to Fuel Growth of its Regenerative Medicine MSC Manufacturing Platform Worldwide, Scale the Organization, and Accelerate R&D Innovation Frederick, MD, Aug. 6, 2019 /PRNewswire-PRWeb/ — RoosterBio…

Precision For Medicine Launches Biospecimen Solutions Offering With Acquisition Of ProMedDx And GLAS

August 1, 2019

ADDITION OF LEADING SUPPLIERS BOLSTERS PRECISION’S BIOMARKER SERVICE OFFERINGS– BRINGING UNPARALLELED SCIENCE, SCALE AND SERVICE TO THE BIOSPECIMEN INDUSTRY BETHESDA, Md., Aug. 1, 2019 /PRNewswire/ — Precision for Medicine, part of Precision…

Regenxbio out-licenses gene therapy vector to Pfizer

July 31, 2019

REGENXBIO (NASDAQ:RGNX) inks an agreement with Pfizer (NYSE:PFE) granting it a non-exclusive global license, with sublicense rights, to its NAV AAV9 vector for the development and commercialization of gene therapies for the…